Desvenlafaxine in the treatment of major depression: an updated overview

TR Norman, JS Olver - Expert opinion on pharmacotherapy, 2021 - Taylor & Francis
Introduction: Major depressive disorder (MDD) remains one of the most prevalent mental
health conditions. It is a chronic, relapsing condition and despite multiple treatment options …

A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive …

W Mi, X Di, Y Wang, H Li, X Xu, L Li, H Wang… - Translational …, 2023 - nature.com
Major depressive disorder (MDD) is the most prevalent form of depression and is becoming
a great challenge for public health and medical practice. Although first-line antidepressants …

Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper

G Sampogna, F Caraci, C Carmassi… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Major depressive disorder (MDD) is a common severe mental disorder,
requiring a tailored and integrated treatment. Several approaches are available including …

The analysis of network structure among the depressive symptoms in a clinical sample of children and adolescents

KM Kim, H Kim, D Kim, JW Kim - Asian journal of psychiatry, 2021 - Elsevier
The symptoms of depressive disorder in children and adolescents vary widely and have
complex interconnections with each other. This study aimed to identify the network structures …

Anxiolytic effect of carvedilol in chronic unpredictable stress model

CNS de Sousa, I da Silva Medeiros… - Oxidative Medicine …, 2022 - Wiley Online Library
Anxiety disorders are the most prevalent psychiatric disorders being also a comorbid state of
other diseases. We aimed to evaluate the anxiolytic‐like effects of carvedilol (CVD), a drug …

Symptom clusters in adolescent depression and differential responses of clusters to pharmacologic treatment

KM Kim, KH Lee, H Kim, O Kim, JW Kim - Journal of Psychiatric Research, 2024 - Elsevier
Objective Symptoms of depression in adolescents are widely variable, but they are often
interactive and clustered. The analysis of interactions and clusters among individual …

[HTML][HTML] Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis

M Kato, Y Asami, DB Wajsbrot, X Wang… - Journal of Psychiatric …, 2020 - Elsevier
Objective To identify clusters of patients with major depressive disorder (MDD) based on the
baseline 17-item Hamilton Rating Scale for Depression (HAM-D 17) items and to evaluate …

[HTML][HTML] Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies

MA Katzman, F Therrien, EM MacKenzie… - Journal of Affective …, 2022 - Elsevier
Background Major depressive disorder (MDD) is a clinically heterogenous condition and its
treatment should be individualized according to the presence of particular symptom clusters …

Network Structure and Clustering Analysis Relating to Individual Symptoms of Problematic Internet Use in a Community Adolescent Population

HS Jeong, HMS Kim, KM Kim - European Addiction Research, 2024 - karger.com
Introduction: Problematic internet use (PIU) is a psychopathology that includes multiple
symptoms and psychological constructs. Because no studies have considered both network …

Prescribing Antidepressant Medication

DS Kroll - Caring for Patients with Depression in Primary Care, 2022 - Springer
First-line antidepressant medications include selective serotonin reuptake inhibitors (SSRIs),
serotonin-norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine. All of …